http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cbef71c6c9ee38c2d2fb7df759bcb6c6
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | O'Brien |
| name | Susan O'Brien |
| given-name | Susan |
| organization-name | From the Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston. Department of Pathology and Microbiology (G.C.) and Department of Companion Animals (T.S.), Atlantic Veterinary College, Charlottetown, PEI, Canada; and Lebanon Equine Clinic, Lebanon, OH (S.B.). From the Departments of Hematology and Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Departments of Leukemia, and Department of Leukemia The University of Texas MD Anderson Cancer Center 1515 Holcombe Boulevard Houston Texas Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX; Chao Family Comprehensive Cancer Center University of California Irvine CA USA 1Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Leukemia and 2Bioinformatics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; and 3Gemin X Pharmaceuticals, Malvern, Pennsylvania From the Departments of Leukemia, Biostatistics, Pediatrics, and Hematopathology, University of Texas M. D. Anderson Cancer Center, Houston. 1Leukemia Department, M. D. Anderson Cancer Center, Houston, Texas; University of California, Irvine, Chao Family Comprehensive Cancer Center, Orange, CA Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX Division of Hematology‐Oncology University of California, Irvine Orange California Department of Leukemia MD Anderson Cancer Center University of Texas Houston Texas Department of Leukemia the University of Texas MD Anderson Cancer Center Houston Texas From the Departments of Leukemia and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Departments ofLeukemia and From the Departments of Leukemia, Hematopathology, and Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston, TX, and Novartis Oncology, East Hanover, NJ. Scottish Government, Marine Laboratory Aberdeen UK From The University of Texas M.D. Anderson Cancer Center, Houston, TX; Duke University, Durham, NC; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Institut Paoli-Calmettes, Marseille, France; Indiana Oncology and Hematology Consultants, Indianapolis, IN; University Hospital Gasthuisbert, Leuven; Cliniques Universitaires Saint-Luc, Brussels, Belgium; Leyenburg Hospital, The Hague; University Hospital of Groningen, Groningen, the Netherlands; The Cleveland Clinic Lerner... From The University of Texas M. D. Anderson Cancer Center, Houston, TX; Duke University Medical Center, Durham, NC; Yakima Regional Cancer Care Center, Yakima, WA; Cross Cancer Institute, Edmonton, AB, Canada; Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego, Cracow, Poland; Instituto Argentino de Diagnostico y Tratamiento SA, Buenos Aires, Argentina; Roswell Park Cancer Institute, Buffalo; Long Island Jewish Medical Center, New Hyde Park, NY; Peter MacCallum Cancer Centre, Melbourne,... From the Departments of Leukemia and Molecular Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Leukemia Department, University of Texas M. D. Anderson Cancer Center, Houston From the University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia The University of Texas, M.D. Anderson Cancer Center Houston Texas From the Departments of Leukemia, Biostatistics, Lymphoma and Myeloma, Epidemiology, and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. University of Texas M. D. Anderson Cancer Center, USA. Chao Family Comprehensive Cancer Center, University of California Irvine Orange California Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. From the Departments of Experimental Therapeutics and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and GlaxoSmithKline, Research Triangle Park, NC Department of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX All authors: University of Texas MD Anderson Cancer Center, Houston, TX. From the Departments of Leukemia and Experimental Therapeutics, MD Anderson Cancer Center, Houston, TX; and ILEX Company, San Antonio, TX. From the Departments of Leukemia, Blood and Marrow Transplantation, and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX From the Departments of Leukemia and Bioimmunotherapy, The University of Texas, M. D. Anderson Cancer Center, Houston, TX; and Novartis Pharmaceuticals, East Hanover, NJ. From the Department of Leukemia and Bioimmunotherapy, University of Texas, M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia University of Texas – MD Anderson Cancer Center Houston Texas From the Departments of Leukemia and of Biostatistics and Applied Mathematics, The University of Texas MD Anderson Cancer Center, Houston, TX; and the Nichols Institute, Quest Diagnostics, San Juan Capistrano, CA. Hagop Kantarjian, Deborah Thomas, and Susan O'Brien, MD Anderson Cancer Center, Houston, TX; and Alan S. Wayne, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Authors' Affiliations: 1Tufts University School of Medicine, Boston, Massachusetts; 2Institute for Drug Development Cancer Therapy and Research Center, San Antonio, Texas; 3Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom; 4Memorial Sloan-Kettering Cancer Center, New York, New York; 5University of California San Diego; 6Biogen Indec, San Diego, California; 7University of Texas M.D. Anderson Cancer Center, Houston, Texas; and 8TGen Clinical Research Services at Scottsdale Healthcare, Scottsdale, Arizona From the Department of Leukemia and Department of Radiology, The University of Texas M.D. Anderson Cancer Center, Houston, TX. From the Departments of Leukemia and Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, and the Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, Little Rock, AR. From the Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston. Department of Leukemia U.T. M.D. Anderson Cancer Center Houston Texas From the Departments of Leukemia, Experimental Therapeutics, Phase I Program, and Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX; University of California San Diego Moore's Cancer Center, San Diego, CA; and Dana-Farber Cancer Institute, Boston, MA Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Departments of Leukemia, From the Departments of Leukemia, Bioimmunotherapy, and Molecular Pathology, University of Texas M. D. Anderson Cancer Center, Houston; and Novartis Pharmaceuticals, East Hanover, NJ. From the Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD; and Bristol-Myers Squibb, Princeton, NJ 2The University of Texas, M. D. Anderson Cancer Center, Houston, Texas; From the Departments of Leukemia, Blood and Marrow Transplantation, Molecular Pathology, and Bioimmunotherapy, The University of Texas MD Anderson Cancer Center, Houston. Department of Leukemia, M.D. Anderson Cancer Center, University of Texas, Houston, TX, USA Department of Leukemia, M. D. Anderson Cancer Center, Houston, TX Departments of Hematology and Clinical Immunology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas Division of Hematology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. sobrien@mdanderson.org From the Departments of Leukemia, Experimental Therapeutics, and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Texas Department of Leukemia University of Texas M.D. Anderson Cancer Center Houston Texas 77030 USA From the Departments of Leukemia and Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Cyclacel, Dundee, United Kingdom. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas Chao Family Comprehensive Cancer Center University of California Irvine Medical Center Orange CA USA 1Leukemia, Departments of From the Department of Leukemia and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Department of Pathology, Ohio State Medical Center, Columbus, OH. From the Departments of Leukemia, Biostatistics and Applied Mathematics, Lymphoma/Myeloma, and Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX Department of Leukemia; The University of Texas; MD Anderson Cancer Center; Houston TX USA From The University of Texas M. D. Anderson Cancer Center, Houston, TX. From the Departments of Leukemia, Biostatistics and Applied Mathematics, and Hematopathology, University of Texas M.D. Anderson Cancer Center, Houston, TX. University of Texas MD Anderson Cancer Center, USA. Departments of Leukemia and From the Departments of Leukemia, Hematopathology, Stem Cell Transplantation and Cellular Therapy, and Biostatistics, University of Texas M.D. Anderson Cancer Center, Houston, TX; and Division of Hematological Malignancies, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD. Departments of Leukemia, Biostatistics, Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX; Departments ofLeukemia, From the Departments of Leukemia and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston. Leukemia Department, University of Texas M. D. Anderson Cancer Center, Houston; Department of Leukemia The University of Texas MD Anderson Cancer Center Houston TX USA From the Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX 5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.; 10Department of Medicine, University of California, Irvine, Chao Family Comprehensive Cancer Center, Irvine, California. Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX; From the Departments of Leukemia and Biostatistics and Applied Mathematics, University of Texas, M. D. Anderson Cancer Center, Houston, TX; and the Department of Hematopathology, Nichols Institute, Quest Diagnostics, San Juan Capistrano, CA. From the Barts Cancer Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom; and The University of Texas MD Anderson Cancer Center, Houston, TX. Department of Leukemia, University of Texas M.D. Anderson Cancer Center, Houston, USA. From the Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX; and Johnson & Johnson Pharmaceutical Research & Development, Titusville, NJ. 12Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. 4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas. From the Departments of Hematopathology and Leukemia, University of Texas MD Anderson Cancer Center, Houston. U.T.M.D. Anderson Cancer Center, Department of Hematology, Box 24, I5I5 Holcombe Blvd., Houston, TX 77030 (713) 792-8750. Chao Family Comprehensive Cancer Center, University of California Irvine Medical Center, Orange, CA. UCI Medical Center, Orange, CA 92868, USA; Chao Family Comprehensive Cancer Center, Orange, CA 92868, USA 12Chao Family Comprehensive Cancer Center, University of California, Irvine, California. Chao Family Comprehensive Cancer Center, University of California-Irvine, Irvine, CA Department of Leukemia University of Texas, MD Anderson Cancer Center Houston TX USA; Chao Family Comprehensive Cancer Center University of Irvine Irvine CA USA From the Department of Leukemia and the Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Departments of 1Leukemia and The University of Texas MD Anderson Cancer Center, Houston, TX; and From the Departments of Leukemia and Biostatistics and Applied Mathematics, The University of Texas M. D. Anderson Cancer Center, Houston, TX. 2Leukemia Department and Susan O'Brien, Deborah Thomas, Hagop Kantarjian, University of Texas, MD Anderson Cancer Center, Houston, TX; Gary Schiller, University of California Los Angeles Medical Center; Dan Douer, University of Southern California Medical Center, Los Angeles; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Stanford University School of Medicine, Stanford; Jeffrey A. Silverman, Steven R. Deitcher, Talon Therapeutics, San Mateo, CA; John Lister, Western... From the Departments of Leukemia and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX. All authors: The University of Texas MD Anderson Cancer Center, Houston, TX. Department of Leukemia University of Texas M. D. Anderson Cancer Center Houston Texas The University of Texas M. D. Anderson Cancer Center, Houston; and From the Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX; From the Departments of Leukemia, Hematopathology, Biostatistics, Infectious Diseases, and Lymphoma, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia University of Texas MD Anderson Cancer Center Houston TX USA 1Leukemia and Departments of University of Texas, Anderson Cancer Center, USA. University of California Irvine Irvine CA 1Bioimmunotherapy and Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; Departments of Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX Division of Cancer Medicine, Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas From the Departments of Leukemia, Bioimmunotherapy, and Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston. MD Anderson Cancer Center, Houston, TX. From the Departments of Leukemia, Lymphoma, and Radiation Oncology, the University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas USA From the Departments of Leukemia, Hematopathology, and Bioimmunotherapy, University of Texas, M. D. Anderson Cancer Center, Houston, TX. The University of Texas M. D. Anderson Cancer Center, Houston Division of Cancer Medicine Department of Leukemia University of Texas MD Anderson Cancer Center Houston Texas From the Departments of Leukemia, Hematopathology, and Lymphoma, The University of Texas M.D. Anderson Cancer Center, Houston, TX, and Department of Hematology and Oncology, Children's Memorial Hospital of Chicago, Chicago, IL. 3Chao Family Comprehensive Cancer Center, UC Irvine, Orange, California. Division of Hematology/Oncology, University of California, Chao Family Comprehensive Cancer Center, Irvine California 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas. Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston; and Departments of Leukemia M. D. Anderson Cancer Center, Houston, TX; From the Departments of Leukemia, Laboratory Medicine, and Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas. From the Departments of Leukemia, Biostatistics, Bone Marrow Transplantation, and Bioimmunotherapy, M.D. Anderson Cancer Center, Houston, TX. From the Department of Hematology and the Department of Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX. Departments of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas 77030 From the Departments of Bioimmunotherapy and Leukemia, M. D. Anderson Cancer Center, Houston, TX, and Schering-Plough Research Institute, Kenilworth, NJ. Department of Hematology/Oncology University of California Irvine California Department of Leukemia, University of Texas, M. D. Anderson Cancer Center, Houston; University of Texas (UT) M. D. Anderson Cancer Center, Houston Departments of Leukemia The University of Texas M.D. Anderson Cancer Center Houston TX USA 2Leukemia and From the Departments of Leukemia and Molecular Hematology, and Division of Laboratory Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and Department of Hematology, Singapore General Hospital, Singapore. University of California, Irvine, California. From the Departments of Leukemia and Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, TX; and ILEX Oncology, San Antonio, TX. From 1The University of Texas MD Anderson Cancer Center; 2Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; 3Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; 4Fred & Pamela Buffett Cancer Center at The Nebraska Medical Center; 5Robert H. Lurie Comprehensive Cancer Center of Northwestern University; 6Memorial Sloan-Kettering Cancer Center; 7Dana-Farber/Brigham & Women's Cancer Center; 8Huntsman Cancer Institute at the University of Utah; 9The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; 10Massachusetts General Hospital Cancer Center; 11Stanford Cancer Institute; 12Vanderbilt-Ingram Cancer Center; 13Fox Chase Cancer Center; 14Duke Cancer Institute; 15St. Jude Children's Research Hospital/The University of Tennessee Health Science Center; 16Moffitt Cancer Center; 17University of Alabama at Birmingham Comprehensive Cancer Center; 18UCSF Helen Diller Family Comprehensive Cancer Center; 19The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; 20City of Hope Comprehensive Cancer Center; 21Roswell Park Cancer Institute; and 22National Comprehensive Cancer Network. From the Section of Molecular Hematology and Therapy, Department of Blood and Marrow Transplantation, the Department of Leukemia, and the Department of Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, TX. The University of Texas M. D. Anderson Cancer Center, Houston, TX Department of Leukemia M. D. Anderson Cancer Center Houston, TX Division of Hematology/Oncology, Department of Medicine University of California Irvine/Orange California USA From the Departments of Hematopathology, Leukemia, and Biostatistics; The University of Texas M. D. Anderson Cancer Center, Houston, TX. Leukemia, and From MD Anderson Cancer Center, Houston, Texas, and University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan. From the University of Texas M. D. Anderson Cancer Center, Houston, TX; Duke University Medical Center, Durham, NC; Yakima Regional Cancer Care Center, Yakima, WA; Cross Cancer Institute, Edmonton, Alberta, Canada; Klinika Hematologii Collegium Medicum Uniwersytetu Jagiellonskiego, Cracow, Poland; Instituto Argentino de Diagnostico y Tratamiento SA, Buenos Aires, Argentina; Roswell Park Cancer Institute, Buffalo; and Long Island Jewish Medical Center, New Hyde Park, NY; Peter MacCallum Cancer Centre and... From the Departments of Leukemia and Bioimmunotherapy, University of Texas M. D. Anderson Cancer Center, Houston, TX. From the Departments of Leukemia, Bioimmunotherapy, Laboratory Medicine, and Biostatistics, The University of Texas, M.D. Anderson Cancer Center, Houston, TX. Chao Family Comprehensive Cancer Center University of California Irvine Orange California USA Department of Leukemia MD Anderson Cancer Center Houston Texas Leukemia Department and Department of Leukemia and |
Incoming Links
Total number of triples: 658.